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a b s t r a c t
Exposure to solar ultraviolet (UV) radiation is a causative factor in skin photocarcinogenesis and photoaging,
and an urgent need exists for improved strategies for skin photoprotection. The redox-sensitive transcription
factor Nrf2 (nuclear factor-E2-related factor 2), a master regulator of the cellular antioxidant defense against
environmental electrophilic insult, has recently emerged as an important determinant of cutaneous damage
from solar UV, and the concept of pharmacological activation of Nrf2 has attracted considerable attention as a
novel approach to skin photoprotection. In this study, we examined feasibility of using tanshinones, a novel
class of phenanthrenequinone-based cytoprotective Nrf2 inducers derived from the medicinal plant Salvia
miltiorrhiza, for protection of cultured human skin cells and reconstructed human skin against solar
simulated UV. Using a dual luciferase reporter assay in human Hs27 dermal ﬁbroblasts pronounced
transcriptional activation of Nrf2 by four major tanshinones [tanshinone I (T-I), dihydrotanshinone (DHT),
tanshinone IIA (T-II-A) and cryptotanshinone (CT)] was detected. In ﬁbroblasts, the more potent tanshinones
T-I and DHT caused a signiﬁcant increase in Nrf2 protein half-life via blockage of ubiquitination, ultimately
resulting in upregulated expression of cytoprotective Nrf2 target genes (GCLC, NQO1) with the elevation of
cellular glutathione levels. Similar tanshinone-induced changes were also observed in HaCaT keratinocytes.
T-I and DHT pretreatment caused signiﬁcant suppression of skin cell death induced by solar simulated UV
and riboﬂavin-sensitized UVA. Moreover, feasibility of tanshinone-based cutaneous photoprotection was
tested employing a human skin reconstruct exposed to solar simulated UV (80 mJ/cm2 UVB; 1.53 J/cm2 UVA).
The occurrence of markers of epidermal solar insult (cleaved procaspase 3, pycnotic nuclei, eosinophilic
cytoplasm, acellular cavities) was signiﬁcantly attenuated in DHT-treated reconstructs that displayed
increased immunohistochemical staining for Nrf2 and γ-GCS together with the elevation of total glutathione
levels. Taken together, our data suggest the feasibility of achieving tanshinone-based cutaneous Nrf2-
activation and photoprotection.
& 2013 The Authors. Published by Elsevier B.V.
Introduction
The redox-sensitive transcription factor Nrf2 (nuclear factor-E2-
related factor 2) has recently emerged as a promising molecular
target for the pharmacological prevention of human pathologies
resulting from exposure to environmental toxicants including poly-
aromatic hydrocarbons (e.g. benzo[a]pyrene), polyhalogenated diox-
ins (e.g. 2,3,7,8-tetrachlorodibenzo-p-dioxin), metals (e.g. cadmium
and arsenic), and electromagnetic radiation [including ionizing
radiation and solar ultraviolet (UV) light] [1–10]. Nrf2 transcriptional
activity orchestrates major cellular defense mechanisms including
phase-II detoxiﬁcation, inﬂammatory signaling, DNA repair, and
antioxidant response thought to underlie tissue protection against
electrophilic environmental insult [1,3,11,12].
Numerous natural products and dietary chemopreventive factors
activate Nrf2 through covalent adduction and/or oxidation of redox-
sensitive thiol residues in Keap1 (Kelch-like ECH-associated protein 1),
the negative regulator of Nrf2 [3,11,13–15]. Inhibition of Keap1-
dependent ubiquitination and subsequent proteasomal degradation
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of Nrf2 allows nuclear translocation, a process followed by Nrf2-
dependent transcriptional activation of cytoprotective target genes
containing an antioxidant response element (ARE) regulatory
sequence such as GCLC (glutamate-cysteine ligase catalytic subunit),
GCLM (glutamate-cysteine ligase rmodiﬁer subunit), TXN (thiore-
doxin), PRDX1 (peroxiredoxin 1), SRXN1 (sulﬁredoxin 1), NQO1 [NAD
(P)H quinone oxidoreductase 1], and HMOX1 (heme oxygenase-1)
[3,11,14,15].
In an attempt to identify therapeutics for improved Nrf2-
directed tissue protection against environmental insult we have
recently focused our research on tanshinones, a novel class of
phenanthrenequinone-based Nrf2-modulators derived from the
medicinal plant Salvia miltiorrhiza. Based on their potent antiox-
idant, anti-inﬂammatory, and cytoprotective activities tanshinones
[including tanshinone I (T-I), dihydrotanshinone (DHT), tanshi-
none IIA (T-II-A), and cryptotanshinone (CT); Fig. 1A] have recently
emerged as experimental and clinically used phytotherapeutics
showing efﬁcacy in the prevention of cardiovascular disease,
ischemia reperfusion injury, and hepatic ﬁbrosis [16–18]. Recently,
we have reported that T-I upregulates Nrf2-orchestrated gene
expression protecting cultured human bronchial epithelial cells
against electrophilic inﬂammatory insult imposed by the environ-
mental toxicant arsenic [19]. In Nrf2 wild-type mice, systemic
administration of T-I attenuated arsenic-induced inﬂammatory
lung damage, a protective effect not observed in Nrf2 KO mice.
Exposure to solar UV-radiation is a causative factor in skin
photocarcinogenesis and photoaging. Even though sunscreen-based
broad spectrum photoprotection is an effective key component of a
sun-safe strategy to reduce cumulative lifetime exposure to UV light,
much effort has been directed towards the identiﬁcation, develop-
ment, and optimization of cutaneous photoprotectants that prevent
and attenuate solar skin damage through mechanisms of action
different from (or synergistic with) photon absorption [20–26].
Recent studies strongly suggest a protective role of Nrf2-mediated
gene expression in the suppression of cutaneous photodamage
induced by solar UV radiation, and Nrf2-activity has been identiﬁed
as a functional determinant of UVA and UVB cytotoxicity in cuta-
neous keratinocytes and ﬁbroblasts [5,6,27–33]. Importantly, Nrf2-
dependent attenuation of UVB-induced sunburn reaction and oxida-
tive DNA damage has been observed in Nrf2 wild-type compared to
Nrf2 KO mice, and it has been demonstrated that UVB-induced
photoaging is accelerated in Nrf2 KO mice as indicated by increased
wrinkle formation, epidermal thickening, dermal deposition of
extracellular matrix, lipid peroxidation, and loss of cutaneous glu-
tathione [6,32,34]. Consequently, the concept of pharmacological
activation of Nrf2 has attracted considerable attention as a novel
approach to skin cell protection against solar damage but improved
agents for Nrf2-directed skin cell photoprotection are needed [35].
In this study, based on the emerging role of Nrf2 activation in
cutaneous defense against photodamage from solar UV and our
previous identiﬁcation of tanshinones as novel cytoprotective Nrf2
inducers, we examined feasibility of tanshinone-based skin photo-
protection. We report for the ﬁrst time that tanshinones are potent
activators of the Nrf2-dependent cytoprotective response in cul-
tured human skin keratinocytes and ﬁbroblasts and that tanshi-
nones protect cultured human skin cells and reconstructed human
skin against cytotoxic doses of solar simulated UV radiation.
Materials and methods
Chemicals
Most chemicals including tanshinones (T-I, T-II-A, DHT, CT)
were purchased from Sigma (St. Louis, MO). Sulforaphane (SF) was
purchased from Santa Cruz (Santa Cruz, CA).
Cell culture
Human dermal neonatal foreskin Hs27 ﬁbroblasts from ATCC
and human immortalized HaCaT keratinocytes were cultured in
DMEM containing 10% fetal bovine serum. Cells were maintained
at 37 1C in 5% CO2, 95% air in a humidiﬁed incubator.
Reconstructed human skin
After shipment refrigerated EpiDerm™ Full Thickness inserts
(EFT-400, 9 mm diameter; MatTek, Ashland, MA) were equili-
brated in 6-well format (5% CO2, 37 1C, 1 h; 0.9 ml of EFT-400-
ASY media per well) followed by change of medium. Two days
before UV exposure, EpiDerm™ tissues were treated by applying
DHT [5 mM ﬁnal concentration in EFT-400-ASY media] or EFT-400-
ASY without DHT, followed by culture at 37 1C. Before irradiation,
inserts were rinsed with PBS and then exposed in 6-well format
Fig. 1. Tanshinones, phenanthrenequinone-based natural products from the med-
icinal plant Salvia miltiorrhiza, cause Nrf2 transcriptional activation in human
dermal ﬁbroblasts. (A) Chemical structure of four major tanshinones [tanshinone I
(T-I), dihydrotanshinone (DHT), tanshinone IIA (T-II-A), and cryptotanshinone (CT)].
(B) After transfection using an expression vector encoding an mGST-ARE ﬁreﬂy
luciferase (F) reporter gene, human dermal Hs27 ﬁbroblasts were exposed to test
compounds (T-I, DHT, T-IIA, CT, SF; 5 mM; 16 h) or remained untreated. A plasmid
encoding renilla luciferase (R) driven by the herpes simplex virus thymidine kinase
promoter was included in all transfections to normalize transfection efﬁciency.
Dual luciferase activities (R/F) were measured, and potency of fold induction is
expressed as relative luminescence units (R/F) versus untreated control transfec-
tants (mean7SD, n¼3; npo0.05).
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with 0.9 ml PBS in the well. After irradiation, PBS was removed
and tissue inserts were cultured for another two days with daily
change of media (EFT-400-ASY media with or without DHT, 5 mM).
At the end of the incubation period, the tissues were rinsed and
then ﬁxed in neutral buffered formalin (10%, 24 h) and then placed
in 70% ethanol followed by parafﬁn embedment and processing for
H&E staining and immunohistochemical analysis.
Irradiation with solar simulated UV light (SSL) and UVA
A KW large area light source solar simulator, model 91293,
from Oriel Corp. (Stratford, CT) was used, equipped with a 1000-W
xenon arc lamp power supply, model 68920, and a VIS-IR band
pass blocking ﬁlter plus either an atmospheric attenuation ﬁlter
(output 290–400 nm plus residual 650–800 nm for solar simu-
lated light) or UVB and UVC blocking ﬁlter (output 320–400 nm
plus residual 650–800 nm, for UVA), respectively [36]. The output
was quantiﬁed using a dosimeter from International Light Inc.
(Newburyport, MA), model IL1700, with an SED240 detector for
UVB (range 265–310 nm, peak 285 nm) or a SED033 detector for
UVA (range 315–390 nm, peak 365 nm) at a distance of 365 mm
from the source, which was used for all experiments. At 365 mm
from the source, SSL dose was 7.63 mJ cm2 s1 UVA and
0.40 mJ cm2 s1 UVB radiation. Using a UVB/C-blocking ﬁlter,
the dose at 365 mm from the source was 5.39 mJ cm2 s1 UVA
radiation with a residual UVB dose of 3.16 mJ cm2 s1.
Transfection of cDNA and luciferase reporter gene assay
Transfection of cDNA was performed using Lipofectamine 2000
(Invitrogen, Carlsbad, CA) used according to the manufacturer's
instruction. Nrf2-dependent transcriptional activity was examined
as previously published [37]. Hs27 ﬁbroblasts were transfected
with an mGST-ARE ﬁreﬂy luciferase reporter plasmid together
with expression plasmids for Nrf2, Keap1, and renilla luciferase
(internal control) using Lipofectamine 2000. At 24 h post-transfec-
tion, cells were treated with test compounds, and after 16 h cells
were lysed for analysis of reporter gene activity. Reporter assays
were performed using the dual-luciferase reporter gene assay
system (Promega, Madison, WI). For each experiment all samples
were run in triplicate, and the data represent the means of three
independent repeats7SD.
UV-impairment of skin cell viability
UV-induced toxicity was measured using the MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] assay.
Brieﬂy, cells (10,000 per well) were seeded on a 96-well plate
and pretreated with test compounds (T-I, DHT, SF; 5 μM, 24 h) or
solvent control (DMSO). Cells were then washed, placed under PBS
(100 mL) and exposed to a dose range of SSL. Alternatively, cells
were placed under PBS containing riboﬂavin (5 mM) and then
exposed to a dose range of solar simulated UVA. After irradiation
cell culture medium was added, and cells were cultured for
another 24 h. For the analysis of survival, MTT (2 mg/ml; 20 μl;
Sigma, St. Louis, MO) was directly added to the cells. After
incubation (37 1C, 2 h), the plate was centrifuged and the medium
was removed by aspiration. Isopropanol/HCl (100 μl) was added to
each well with shaking at room temperature. Absorbance was then
measured at 570 nm using the Synergy 2 Multi-Mode Microplate
Reader (Biotek, Seattle, USA). All samples were run in triplicate for
each experiment, and the data represent the means of three
independent experiments.
Immunoblot analysis, ubiquitination assay, and determination of
protein half-life
Antibodies for Nrf2 (sc-13032), Keap1 (sc-15246), NQO1
(sc-32793), γ-GCS (sc-55586) and GAPDH (sc-32233) were pur-
chased from Santa Cruz (Santa Cruz, CA). Cells were harvested in
sample buffer [50 mM Tris–HCl (pH 6.8), 2% SDS, 10% glycerol,
100 mM DTT, and 0.1% bromophenol blue]. After sonication, cell
lysates were electrophoresed through an SDS–polyacrylamide gel
and subjected to immunoblot analysis. For ubiquitination assay,
Hs27 cells were co-transfected with expression vectors for HA-
tagged ubiquitin and Nrf2, and after 24 h cells were then treated
with SF, T-I or DHT (5 μM, each; 4 h) along with MG132 (10 μM)
[38]. Cells were then harvested in buffer [2% SDS, 150 mM NaCl,
10 mM Tris–HCl (pH 8.0), 1 mM DTT] and immediately boiled. The
lysates were then diluted ﬁvefold in buffer lacking SDS and
incubated with anti-Nrf2 antibody. Immunoprecipitated proteins
were analyzed by immunoblotting using an antibody directed
against the HA epitope (Santa Cruz). To measure Nrf2 protein half-
life, Hs27 ﬁbroblasts were either left untreated or treated with test
compounds (DHT or T-I; 5 μM, 4 h). Cycloheximide (CHX, 50 μM)
was added to block protein synthesis. Total cell lysates were
collected at different time points and subjected to immunoblot
analysis with anti-Nrf2 antibody. The relative intensity of the
bands was quantiﬁed using the ChemiDoc CRS gel documentation
system and Quantity One software from BioRad (Hercules, CA).
Real-time reverse transcription-polymerase chain reaction (RT-PCR)
RT-PCR was done on total mRNA extracted from cells using
TRIZOL reagent (Invitrogen, Grand Island, NY). Equal amounts of
mRNA were used to generate cDNA using the Transcriptor First
Strand cDNA synthesis kit purchased from Roche (Roche, Indiana-
polis, IN). The PCR condition, Taqman probes and primers for
hNFE2L2 (Nrf2), NQO1, GCLM, and GAPDH were reported pre-
viously [19]. Brieﬂy, Taqman probes were purchased from the
universal probe library (Roche, Indianapolis, IN): hNFE2L2 (#70),
hNQO1 (#87), hGCLM (#18), and hGAPDH (#25). Primers were
synthesized by Sigma.
hNFE2L2: forward (acacggtccacagctcatc) and reverse
(tgtcaatcaaatccatgtcctg);
hNQO1: forward (atgtatgacaaaggacccttcc) and reverse
(tcccttgcagagagtacatgg);
hGCLM: forward (gacaaaacacagttggaacagc) and reverse
(cagtcaaatctggtggcatc);
hGAPDH: forward (ctgacttcaacagcgacacc) and reverse
(tgctgtagccaaattcgttgt).
The real-time PCR conditions used were the following: one
cycle of initial denaturation (95 1C, 10 min), 40 cycles of
ampliﬁcation (95 1C, 10 s; 60 1C, 20 s), and a cooling period
(50 1C, 5 s). Mean crossing point (Cp) values and standard
deviations were determined. Cp values were normalized to
the respective crossing point values of the hGAPDH reference
gene. Data are presented as fold change in gene expression as
compared to the control group. All quantitative RT-PCR data
were generated in three independent experiments performed
in duplicates. Data are all presented as means7SD.
Detection of intracellular oxidative stress by ﬂow cytometric analysis
Induction of intracellular oxidative stress by UVA/riboﬂavin
photosensitization was analyzed by ﬂow cytometry using 2′,
7′-dichlorodihydroﬂuorescein diacetate (DCFH-DA) as a sensi-
tive nonﬂuorescent precursor dye according to a published
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standard procedure [22,23]. One hour after irradiation, DCFH-
DA (5 μg/ml ﬁnal concentration) was added to the culture
medium and cells were incubated for 1 h in the dark (37 1C,
5% CO2). Cells were harvested, washed with PBS, resuspended
in 300 μl PBS and immediately analyzed by ﬂow cytometry. To
avoid direct photooxidation of the dye probe, cells were loaded
with the indicator dye under light exclusion.
Glutathione assays
Total intracellular glutathione in cultured cells was analyzed
using the QuantiChrom glutathione assay kit (BioAssay Systems)
according to the manufacturer's instructions. The experiment was
conducted in duplicates in three independent repeats. For glu-
tathione determination in skin reconstructs, specimens ﬁrst
underwent epidermal–dermal separation and dispase-digest
(1 U/ml, 37oC; sterile dispase I, from Bacillus polymyxa, Roche
Applied Science) to recover keratinocytes from the epidermal
portion following a standard procedure available from the manu-
facturer (EFT-400, MatTek, Corp.). Resuspended dissociated cells
were counted using a Z2 Coulter counter, and GSH was determined
per 10,000 viable cells using the ultrasensitive luminescent GSH-
GloTM glutathione assay (Promega, Madison, WI). Data represent
relative levels of glutathione normalized for cell number compar-
ing treated versus solvent controls (means7SD; n¼3).
Hematoxylin and eosin (H&E) staining and
immunohistochemistry (IHC)
Reconstructed skin samples were stained using hematoxylin and
eosin (H&E) according to standard procedures [39]. IHC analysis was
performed as previously described. Following antigen retrieval, tissue
Fig. 2. Tanshinone I and dihydrotanshinone upregulate protein levels of Nrf2 and Nrf2 targets in human dermal ﬁbroblasts. (A) Dose–response relationship of tanshinone-
induced the upregulation of Nrf2 protein levels. Hs27 ﬁbroblasts were exposed to four types of tanshinones (T-I, DHT, T-IIA, CT; 5 mM, each; 4 h) followed by immunoblot
analysis. SF (5 μM; 4 h) treatment was included as a positive control. (B) Time course of tanshinone-induced the upregulation of Nrf2, NQO1, and γ-GCS. Hs27 ﬁbroblasts were
exposed to tanshinones (T-I, DHT; 5 mM, 2–24 h) and total cell lysates were subjected to immunoblot analysis. Detection of GAPDH served as a loading control.
(C) Quantitative analysis of triplicate gels as presented in panel A. (D) Quantitative analysis of triplicate gels as presented in panel B. Relative intensity of protein bands was
determined using gel documentation software as described in “Materials and methods” (mean7SD, n¼3; npo0.05).
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sections were incubated with 5% normal goat serum for 30 min
followed by 2 h incubation using the respective antibodies [Nrf2, γ-
GCS (as described above), cleaved caspase 3 (Asp175; 9664, Cell
Signaling, Danvers, MA)] [23]. Sections were incubated with a
biotinylated secondary antibody. The ABC kit (Vector Laboratories,
Burlingame, CA) was then used according to the manufacturer's
instructions. Tissue sections were developed using the 3,3′-diamino-
benzidine staining kit (DAKO, Carpinteria, CA), and counterstained
with hematoxylin.
Statistics
All the results are presented as the means7SD of at least three
independent experiments performed in duplicate or triplicate each.
Data were analyzed employing the two-sided Student's t-test; differ-
ences were considered signiﬁcant at po0.05 (npo0.05; nnpo0.01;
nnnpo0.001). Selected data sets were analyzed employing one-way
analysis of variance (ANOVA) with Tukey's post hoc test using the
PRISM 4.0 software; means without a common letter differ (po0.05).
Results
Identiﬁcation of tanshinone I and dihydrotanshinone as potent
Nrf2-inducers in human dermal ﬁbroblasts
In an attempt to explore the Nrf2-based cytoprotective poten-
tial of tanshinones against environmental exposure we aimed at
Fig. 3. Tanshinones increase Nrf2 half-life via interference with ubiquitination, elevate intracellular glutathione, and protect dermal ﬁbroblasts against UV-induced cytotoxicity.
(A) Tanshinone-modulation of Nrf2 and Nrf2 target gene expression. Hs27 Fibroblasts were treated with T-I and DHT (5 μM; 16 h) and mRNA was extracted. The relative mRNA
levels of Nrf2 and its downstream genes (NQO1, GCLM) were determined by quantitative real-time RT-PCR with triplicate samples in each experiment. The experiment was
conducted in triplicate and expressed as mean7SD (*po0.05). (B) Tanshinone-modulation of Nrf2-ubiquitination. Hs27 cells were co-transfected with plasmids encoding the
indicated proteins (Nrf2, HA-Ub). Cells were then treated with SF, T-I or DHT (5 μM; 4 h) along with MG132 (10 μM; 4 h) before cell lysates were collected for the ubiquitination
assay. For the detection of ubiquitin-conjugated Nrf2, anti-Nrf2 immunoprecipitates were analyzed by immunoblotting using an anti-HA antibody. (C) Tanshinone-modulation of
Nrf2 protein half-life. Hs27 cells were left untreated or treated with T-I or DHT (5 μM; 4 h). Cycloheximide (50 μM) was added and cells were harvested at the indicated time points
(0–45 min). Cell lysates were subjected to immunoblot analysis using anti-Nrf2 and anti-GAPDH antibodies. The intensity of the bands was quantiﬁed using Quantity One software
and plotted against the time after cycloheximide treatment. (D) Intracellular total glutathione levels relative to untreated control were determined in ﬁbroblasts exposed to
tanshinones (T-I, DHT) or SF (5 μM, each; 24 h) using the QuantiChrom glutathione assay kit as detailed in Materials and Methods. (E and F) To assess cytoprotective effects of
tanshinone treatment on UV-induced cytotoxicity, ﬁbroblasts were ﬁrst preincubated in the presence of T-I or DHT (5 mM; 24 h) and then exposed to full spectrum solar simulated
UV [solar simulated light (SSL); panel E] or solar simulated UVA delivered in the presence of the photosensitizer riboﬂavin [5 μM (UVAþriboﬂavin); panel F], followed by
assessment of cell viability at 24 h post-irradiation. Data are expressed as means7SD (npo0.05; n¼3).
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testing selected tanshinones for skin cell photoprotection against
solar UV radiation. To this end, potency of transcriptional activa-
tion of Nrf2 in Hs27 human dermal ﬁbroblasts was compared
among four major tanshinones (T-I, DHT, T-II-A, CT) using a dual
luciferase reporter assay employing an mGST-ARE ﬁreﬂy luciferase
plasmid (Fig. 1B). Exposure to tanshinone test compounds caused a
signiﬁcant 1.5–2.5-fold upregulation of Nrf2 transcriptional activ-
ity over untreated controls, and T-I or DHT were signiﬁcantly more
potent than T-II-A or CT (5 mM, each), with DHT causing a similar
degree of induction as an equimolar dose of the isothiocyanate-
based Nrf2 inducer sulforaphane (SF).
Next, tanshinone-induced Nrf2 activation was examined at the
protein level employing immunoblot analysis (Fig. 2). Fibroblasts
were exposed to a dose range of test compounds (T-I, DHT, T-II-A,
CT; 2–40 mM; 4 h), and modulation of cellular Nrf2 protein levels
was examined. As already observed by luciferase-based assess-
ment of Nrf2 transcriptional activity (Fig. 1B), all tanshinones
caused an increase in Nrf2 protein levels in a dose-dependent
manner, whereas no effects were observed on Keap1 protein
levels. T-I or DHT were signiﬁcantly more potent than CT or T-II-
A, upregulating Nrf2 levels at concentrations equal or above 2 mM
(Fig. 2A and C). CT displayed attenuated activity, upregulating Nrf2
protein levels only at concentrations equal or above 10 mM, and
T-II-A displayed only minimal activity.
Next, time course analysis of Nrf2 modulation by T-I or DHT
(5 mM; 2–24 h) was conducted monitoring protein levels of Nrf2
and Nrf2 targets (NQO1, γ-GCS) (Fig. 2B and D). A signiﬁcant
increase in Nrf2 protein level was observable at early time points
(2 h) and persisted for up to 12 h for both tanshinones, whereas no
changes were observed with Keap1 protein levels (Fig. 2B). At later
time points Nrf2 protein levels returned to basal levels, whereas
protein levels of the Nrf2 target proteins displayed sustained
upregulation (24 h). Based on the appreciable Nrf2 activation
displayed by T-I and DHT that surpassed that of T-II-A and CT,
we pursued further experimentation focusing on T-I and DHT.
Tanshinones increase Nrf2 protein half-life via blockage of
ubiquitination, elevating intracellular glutathione and protecting
dermal ﬁbroblasts against solar UV-induced cytotoxicity
After examining dose–response relationship and time course of
tanshinone-induced modulation of Nrf2 at the protein level, we
examined Nrf2 mRNA levels in tanshinone treated cells. However,
no changes were observed in response to either tanshinones (T-I,
DHT; 5 mM; 16 h) or the standard Nrf2 inducer SF (5 μM; 16 h)
(Fig. 3A). In contrast, exposure to T-I or DHT upregulated expres-
sion of Nrf2 target genes (NQO1 and GCLM) at the mRNA level by
up to threefold, an induction equal or superior to that observed in
response to SF (Fig. 3A). Taken together these data indicate that in
dermal ﬁbroblasts T-I and DHT activate the Nrf2 pathway by
upregulation of Nrf2 at the protein level.
Next, we investigated the molecular mechanism underlying
Nrf2 activation by T-I and DHT in more detail. As demonstrated
previously, established Nrf2 inducers such as SF and tBHQ cause
Nrf2 activation through inhibition of the Keap1-mediated ubiqui-
tination of Nrf2 [40]. Therefore a cellular ubiquitination assay was
performed using Hs27 ﬁbroblasts co-transfected with expression
vectors for Nrf2 and hemagglutinin (HA)-ubiquitin, followed by
immunoprecipitation of Nrf2 and immunodetection of ubiquiti-
nated protein using an anti-HA antibody. After transfection, cells
were either left untreated or exposed to T-I, DHT, or SF. In cells
treated with T-I or DHT (5 μM; 4 h), ubiquitination of Nrf2
decreased dramatically compared to untreated control (Fig. 3B).
As expected, SF (5 μM; 4 h) also decreased Nrf2 ubiquitination
(Fig. 3B). Next, the half-life of endogenous Nrf2 protein was
measured. Cycloheximide (CHX) was added to either untreated
or tanshinone-exposed Hs27 ﬁbroblasts (5 mM; 4 h pretreatment)
followed by quantitative determination of Nrf2 by immunoblot
analysis (Fig. 3C, right panel). Intensity of Nrf2 bands was deter-
mined densitometrically and plotted as a function of time after
addition of CHX, and the half-life of Nrf2 was calculated (Fig. 3C,
left panel). The half-life of Nrf2 under untreated conditions
(control) was 16.6 min, whereas Nrf2 half-life almost doubled
(32.2 min) following T-I treatment and was increased more than
2.3-fold (38.9 min) in response to DHT treatment (5 μM, each).
Taken together, these results indicate that T-I and DHT induce
the Nrf2-dependent stress response in dermal ﬁbroblasts by
decreasing Nrf2 ubiquitination causing stabilization of Nrf2 at
the protein level.
Next, we tested feasibility of raising cellular glutathione levels
by tanshinone treatment in dermal ﬁbroblasts (Fig. 3D). Indeed,
intracellular concentrations of total glutathione were signiﬁcantly
increased by approximately 35–40% over untreated control cells
when ﬁbroblasts were exposed to tanshinones (T-I or DHT, 5 mM;
24 h), a ﬁnding consistent with Nrf2-dependent upregulation of
GCLM mRNA and ©-GCS protein levels as detailed above (Figs. 2 B
and 3A). Again, as observed with modulation of Nrf2 protein half
life (Fig. 3C), DHT was slightly more efﬁcacious than T-I causing a
similar increase of cellular glutathione content as observed in
response to treatment with SF (5 μM; 24 h) used as a reference
Nrf2-inducer (Fig. 3D).
Earlier research has demonstrated that Nrf2-dependent upregula-
tion of intracellular glutathione is a key factor mediating photo-
protective effects of Nrf2 against solar UV-induced skin cell damage
[5]. After demonstrating tanshinone-induced Nrf2 activation and
modulation of cellular glutathione status, we therefore assessed
cytoprotective effects of tanshinone preincubation on UV-induced
cytotoxicity in dermal ﬁbroblasts (Fig. 3E and F). Cells were ﬁrst
preincubated in the presence of T-I or DHT (5 mM; 24 h) and then
exposed to a broad dose range of either full spectrum solar simulated
UV [UVA plus UVB; solar simulated light (SSL); Fig. 3E], followed by
assessment of cell viability at 24 h post-irradiation. In addition,
exposure to solar simulated UVA was employed. Speciﬁcally, UVA
was delivered in the presence of the photosensitizer riboﬂavin
[vitamin B2, 5 μM (UVAþriboﬂavin); Fig. 3F], an accepted model of
UVA-induced photooxidative stress enhanced by inclusion of an
endogenous UVA-photosensitizer [41,42]. As a positive control,
photoprotective activity of SF, shown earlier to suppress skin cell
photodamage in response to solar UV exposure, was also assessed
[6,29,35]. Remarkably, tanshinone (T-I, DHT) pretreatment signiﬁ-
cantly attenuated SSL-induced loss of ﬁbroblast viability, increasing
the proportion of cells surviving apoptogenic doses of SSL (up to
9.2 J/cm2 UVA plus 480 mJ/cm2 UVB; Fig. 3E) more than twofold.
Equally, signiﬁcant suppression of riboﬂavin-enhanced UVA photo-
toxicity (UVA doses up to 6 J/cm2), was observed when cells received
either T-I or DHT pretreatment (Fig. 3F). Protection against SSL-
induced cytotoxicity did not differ between T-I- and DHT-treated
cells, but DHT was signiﬁcantly more potent than T-I protecting
ﬁbroblasts against riboﬂavin-enhanced UVA phototoxicity. Taken
together, these data indicate feasibility of tanshinone-based Nrf2-
activation, glutathione upregulation, and solar photoprotection of
dermal ﬁbroblasts.
Tanshinone-based Nrf2 activation protects HaCaT keratinocytes and
reconstructed human skin against solar UV-induced cytotoxicity
Next, human HaCaT keratinocytes were exposed to a dose
range of tanshinones (T-I and DHT; 2.5–20 mM; 4 h), and modula-
tion of Nrf2 protein levels was monitored by immunoblot analysis
(Fig. 4A). Pronounced upregulation of Nrf2 protein levels was
observed at low micromolar concentrations (T-I: 2.5 and 5 μM;
DHT: 2.5 mM), similar to that induced by SF (5 μM; 4 h). Next, a
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time course analysis of Nrf2 modulation by T-I or DHT was
conducted (Fig. 4B). Exposure to T-I or DHT (2.5 mM, each) caused
a rapid increase in Nrf2 protein levels within 2 h exposure time
detectable for up to 12 h, and Nrf2 upregulation occurred at
concentrations as low as 0.5 mM (Fig. 4B). At 24 h Nrf2 protein
levels almost returned to basal levels, but protein levels of Nrf2
downstream targets (NQO1, γ-GCS) displayed sustained upregula-
tion even at later time points (24 h; Fig. 4B). In contrast, Keap1
protein levels remained unchanged over 24 h exposure time.
Next, feasibility of raising cellular glutathione levels in res-
ponse to tanshinone exposure was tested in HaCaT keratinocytes.
Consistent with Nrf2-dependent upregulation of total cellular
glutathione as observed in tanshinone-exposed dermal ﬁbro-
blasts (Fig. 3D), glutathione levels in HaCaT keratinocytes were
signiﬁcantly increased by up to 30% over untreated controls in
response to exposure to T-I or DHT (2.5 mM, 24 h; Fig. 4C).
Next, we assessed the protective effects of tanshinone preincu-
bation on UVA-induced photooxidative stress in HaCaT keratino-
cytes (Fig. 4D). To this end, cells were ﬁrst preincubated in the
absence or presence of DHT (2.5 mM; 3 or 24 h preincubation
time), followed by exposure to the combined action of UVA and
vitamin B2. Cellular oxidative stress was then assessed 1 h after
irradiation employing ﬂow cytometric detection of DCF ﬂuores-
cence. Indeed, DHT preincubation efﬁciently suppressed UVA/B2-
induced photooxidative stress causing an almost threefold sup-
pression of UVA/B2-induced DCF ﬂuorescence intensity. Remark-
ably, this effect was only observed if DHT preincubation occurred
during an extended period of time (24 h) whereas short term
preincubation (3 h) was not sufﬁcient to protect cells against UVA-
induced photooxidative stress, a ﬁnding consistent with DHT
acting through Nrf2-dependent biological upregulation of cellular
antioxidant defenses (e.g. biosynthesis of glutathione) rather than
through direct antioxidant chemical reactivity.
Next, tanshinone-based [T-I or DHT (2.5 mM; 24 h)] photoprotec-
tion of HaCaT keratinocytes was examined employing a dose range of
full spectrum solar simulated UV [SSL], followed by assessment of cell
viability at 24 h post-irradiation (Fig. 4E). As a positive control,
photoprotective activity of the standard Nrf2-inducer SF was also
Fig. 4. Tanshinones activate Nrf2 in HaCaT keratinocytes and reconstructed human skin providing protection against solar UV-induced cytotoxicity. (A) Dose–response
relationship of tanshinone-induced upregulation of Nrf2 protein levels. HaCaT cells were exposed to tanshinones (T-I, DHT; 5 mM, each; 4 h) followed by immunoblot
analysis. SF (5 μM; 4 h) treatment was included as a positive control. Detection of GAPDH served as a loading control. (B) Time course of tanshinone-induced modulation of
Nrf2, Keap1, γ-GCS, and NQO1. HaCaT cells were exposed to tanshinones (T-I, DHT; 0.5 and 2.5 mM, 2–24 h), and total cell lysates were subjected to immunoblot analysis.
Detection of GAPDH served as a loading control. In addition, NQO1 samples are shown with their own GAPDH loading control. (C) Intracellular total glutathione levels
relative to untreated control were determined in HaCaT cells exposed to tanshinones (T-I, DHT; 0.5 and 2.5 mM) using the QuantiChrom glutathione assay kit as detailed in
“Materials and methods”. (D) Modulation of cellular oxidative stress was examined in cells preincubated in the absence or presence of DHT (2.5 mM; 3 or 24 h preincubation
time) followed by exposure to the combined action of UVA (1.5 J/cm2) and vitamin B2 (5 mM). One hour after irradiation ﬂow cytometric detection of DCF ﬂuorescence was
performed. One representative histogram is shown (control versus UVA/B2 versus UVA/B2þDHT (24 h, preincubation). Bar graph depicts summary data of at least three
independent repeats (nZ3, mean7SD). Data were analyzed employing one-way analysis of variance (ANOVA) with Tukey's post hoc test. Means without a common letter
differ (po0.05). (E) Cytoprotective effects of tanshinone treatment on UV-induced cytotoxicity. HaCaT cells were ﬁrst preincubated in the presence of T-I or DHT (2.5 mM;
24 h) and then exposed to full spectrum solar simulated UV [solar simulated light (SSL); upper panel] followed by assessment of cell viability at 24 h post-irradiation. Data
are expressed as means7SD (npo0.05; n¼3).
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assessed. As observed before with dermal ﬁbroblasts (Fig. 3E),
tanshinone (T-I, DHT) pretreatment signiﬁcantly attenuated SSL-
induced loss of keratinocyte viability, increasing the proportion of
cells still viable after receiving apoptogenic doses of SSL (up to 4.8 J/
cm2 UVA plus 250 mJ/cm2 UVB) by approximately 50%. Differences in
protective efﬁcacy against SSL-induced cytotoxicity between T-I- and
DHT-treated cells did not reach the level of statistical signiﬁcance.
Next, feasibility of tanshinone-based cutaneous photoprotection
was tested directly using an organotypic model of human skin
(Fig. 5). A full thickness human skin reconstruct with differentiated
viable epidermis was employed. First, the effect of tanshinone
exposure on epidermal glutathione levels was examined, and
tanshinone-induced upregulation of Nrf2 and the Nrf2-target γ-GCS
was monitored. To this end, growth mediumwas supplemented with
T-I or DHT (5 mM, each; 24 and 48 h), and control reconstructs
remained untreated (Fig. 5A). Following enzymatic (dispase-depen-
dent) recovery of viable keratinocytes from the epidermis elevation
of total glutathione levels was observable in DHT exposed skin
specimens, an effect that reached the level of statistical signiﬁcance
upon prolonged exposure (48 h) displaying an approximately 1.25-
fold increase over untreated control specimens. Since DHT caused a
more pronounced elevation of epidermal glutathione than T-I, the
subsequent skin photoprotection experiment employed DHT as
experimental Nrf2 inducer. Indeed, DHT-induced upregulation of
Nrf2 and γ-GCS protein levels was conﬁrmed by immunohistochem-
ical (IHC) analysis (Fig. 5B). In response to DHT exposure pronounced
nuclear localization of Nrf2 and increased expression levels of γ-GCS
were observed. Next, feasibility of achieving DHT-induced skin
photoprotection against solar UV was tested. To this end, solar UV
insult was caused by exposure of reconstructed human skin to SSL
(80 mJ/cm2 UVB; 1.53 J/cm2 UVA), delivering a UVB dose shown
earlier to impair keratinocyte viability and to disrupt structural
integrity of reconstructed human skin with sunburn cell formation
and caspase 3 activation [43,44]. Two days before exposure, growth
medium was either supplemented daily with DHT (5 mM) or
remained unsupplemented. Two days after irradiation reconstructs
were harvested, and occurrence of keratinocyte photodamage was
examined by H&E staining and immunohistochemical visualization
of cleaved procaspase 3 (active caspase 3; Fig. 5C and D). Strikingly,
H&E staining revealed the occurrence of tissue damage in response
to SSL exposure as obvious from (i) the presence of pycnotic nuclei
with eosinophilic cytoplasmic staining (“sunburn” cells), (ii) the
occurrence of acellular cavities indicative of massive loss of epider-
mal cellularity, and (iii) reduced epidermal thickness, consistent with
UV-induced cell death and inhibition of proliferation that impair
epidermal growth and viability over the three-day post-irradiation
period [43,44]. Moreover, staining for cleaved procaspase 3 (activated
caspase 3), a hallmark of UV-induced epidermal photodamage, was
detectable in keratinocytes of reconstructed human skin exposed to
SSL (Fig. 5C), a ﬁnding consistent with published research that has
documented caspase 3 cleavage in epidermal keratinocytes of
reconstructed human skin exposed to UVB, delivered at doses
comparable to the one used in this study [43]. In contrast, the
occurrence of markers of solar damage was signiﬁcantly attenuated
in SSL-exposed DHT-treated reconstructs, that displayed a signiﬁcant
almost threefold reduction in the number of sunburn cells (Fig. 5C
and D) and an approximately twofold reduction in the number of
caspase 3 positive nuclei (Fig. 5C; numerical analysis not depicted).
These observations demonstrate feasibility of protecting recon-
structed human skin against solar UV-induced loss of keratinocyte
viability using the tanshinone DHT that upregulates Nrf2 and
cytoprotective Nrf2 targets including glutathione.
Fig. 5. Tanshinone-based cutaneous Nrf2 activation, glutathione upregulation, and protection against solar UV exposure. (A) Elevation of total cellular glutathione levels in
keratinocytes from skin specimens cultured in growth medium supplemented with tanshinones (DHT or T-I, 5 mM each; 24 and 48 h exposure; nZ3; mean7SD) or cultured
in based medium without supplementation. After culture, keratinocytes were retrieved from skin reconstructs by dispase-digest, and glutathione levels were normalized to
cell number. (B) Two days before SSL (80 mJ/cm2 UVB; 1.53 J/cm2 UVA) exposure, growth medium was supplemented with DHT (5 mM), whereas control reconstructs
remained untreated. (C) Upregulation of Nrf2 and γ-GCS was examined by immunohistochemical analysis of human skin reconstructs after exposure to growth medium
supplemented with DHT (5 mM, each; 48 h). Controls remained untreated; scale bar¼25 mm. Two days after SSL exposure reconstructs were harvested and processed for IHC.
Arrowheads indicate localization of photodamaged keratinocytes (H&E: pycnotic nuclei, eosinophilic cytoplasm, loss of cellularity; IHC: cleaved procaspase 3; scale
bar¼50 mm). Per treatment group representative images taken from three independent repeat samples are displayed. (D) The bar graph displays quantitative analysis of
keratinocyte photodamage [percentage of sunburn cells per high power ﬁeld; at least three independent skin reconstructs per group (mean7SD); one-way analysis of
variance (ANOVA) with Tukey's post hoc test]. Means without a common letter differ (po0.05).
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Discussion
Exposure to chronic solar UV-radiation is a causative factor
underlying cutaneous photocarcinogenesis and photoaging. The
importance of efﬁcient skin UVB (290–320 nm) photoprotection
that attenuates photomutagenic events originating from direct
absorption of UVB photons by DNA bases is ﬁrmly established as
reviewed recently [20,21,23,45]. In addition, cumulative evidence
for the involvement of chronic UVA exposure in the causation of
solar skin damage, thought to occur through photooxidative
mechanisms mediated by reactive oxygen species (ROS), now
dictates the necessity for additional broad spectrum skin photo-
protection that includes the UVA spectral region of sunlight
[25,46]. Signiﬁcant research has focused on the identiﬁcation of
molecular interventions and agents designed to provide synergis-
tic photoprotective beneﬁt if used together with sunscreen appli-
cation (referred to as “non-sunscreen photoprotection”) as
reviewed previously [26,47–52].
Recently, pharmacological activation of Nrf2 has been explored as
a novel strategy for skin cell photoprotection, and a limited number
of prototype agents has shown efﬁcacy [6,28,29,33,35,53,54]. Speci-
ﬁcally, It has been shown earlier that pharmacological Nrf2-
activation by topical administration of the Nrf2 inducer sulforaphane
suppresses UVB-induced acute inﬂammation and sunburn reaction
in murine skin [6], and topical application of broccoli sprout extracts
containing sulforaphane protected against UVB-induced skin carci-
nogenesis in SKH1 hairless mice [28], but the photochemopreventive
activity of topical sulforaphane application has also been attributed
to potent inhibition of AP-1 [55]. Moreover, the small molecule Nrf2
activator cinnamaldehyde displayed strong cytoprotective activity by
suppressing reactive oxygen species (ROS)-dependent photooxida-
tive stress in cultured skin keratinocytes and ﬁbroblasts [53], and the
photoprotective potential of a synthetic tricyclic bis(cyanoenone)-
based Nrf2 inducer has been substantiated by demonstrating sup-
pression of UVA-induced skin photooxidative stress in a murine
model of systemic immunomodulatory thiopurine therapy [33].
Recently, combined chemical and in silico screening using the
commercial LOPAC1280 library has identiﬁed a series of synthetic,
drug-like Nrf2 activators including the experimental PPARγ inhibitor
GW9662 (2-chloro-5-nitro-N-phenyl-benzamide) that displayed low
toxicity and protected primary human keratinocytes from UVB-
induced cell death [35].
Based on the emerging photoprotective potential of small mole-
cule Nrf2 activators and the urgent need for improved Nrf2-directed
agents with deﬁned pharmacokinetic and toxicological proﬁle, sys-
temic availability, and established prior clinical performance in
human patients, we have focused our attention on tanshinones, a
class of medicinal plant-derived phytopharmaceuticals with docu-
mented use and efﬁcacy in human patients for antioxidant and anti-
inﬂammatory cardiovascular intervention. Here we have demon-
strated that tanshinones are potent Nrf2-activators in cultured
human skin keratinocytes and ﬁbroblasts (Figs. 1–4). Our experi-
ments demonstrate that in human skin cells the more potent
tanshinones TI and DHT antagonize ubiquitination-dependent turn-
over of Nrf2 (Fig. 3), thereby extending Nrf2 protein half-life and
upregulating Nrf2 transcriptional activity with increased expression
of numerous cytoprotective target genes at the mRNA and protein
levels (Figs. 1–3). Among the four tested tanshinones, DHT displayed
the most pronounced Nrf2-directed effects including Nrf2 transcrip-
tional activation (Fig. 1B) and upregulation of Nrf2 protein half life
(Fig. 3C), and was also slightly more effective in raising cellular
glutathione and protecting skin cells against solar UV-induced cell
death and photooxidative stress (Figs. 3 D–F and 4D–E). However, the
structural basis underlying differential potency of Nrf2 activation
observed among the four tanshinones tested by us in skin cells
remains to be elucidated.
Recently, upregulation of cellular glutathione levels has been
identiﬁed as an important determinant of Nrf2-dependent
cyto- and photoprotective activity, and it has been demonstrated
that Nrf2 establishes a glutathione-mediated gradient of UVB-
cytoprotection in the epidermis [5]. Indeed, TI and DHT treat-
ment upregulated gene expression underlying glutathione bio-
synthesis in cultured skin cells and reconstructed human skin
(Figs. 2, 3 A, and 4B), and a signiﬁcant elevation of cellular
glutathione levels (between 20 and 40% of untreated controls)
was detectable in cultured keratinocytes and ﬁbroblasts exposed
to TI and DHT (Figs. 3 D and 4C). However, it remains to be seen if
glutathione modulation is the key mechanistic determinant of
the photoprotective activity achieved by tanshinone pretreat-
ment of cultured ﬁbroblasts [SSL (Fig. 3E); riboﬂavin-enhanced
UVA (Fig. 3F)], keratinocytes [riboﬂavin-enhanced UVA (Fig. 4D);
SSL (Fig. 4E)] and human reconstructed skin [SSL (Fig. 5)]. Indeed,
other factors beyond Nrf2-dependent glutathione upregulation
may potentially contribute to tanshinone-induced photoprotec-
tion including the modulation of DNA repair and survival signal-
ing pathways all known to be controlled in part by Nrf2, a
question to be addressed by future experiments.
In the context of pharmacological modulation of Nrf2 for skin
photoprotection, it should be mentioned that Nrf2-activating muta-
tions have been identiﬁed in cutaneous squamous cell carcinomas
[56]. It has recently been observed that stable overexpression of
Nrf2 may result in enhanced resistance of cancer cells to che-
motherapeutic agents, and that constitutive activation of Nrf2
function during tumor progression may promote tumorigenicity
conferring chemoresistance by upregulation of glutathione, thior-
edoxin, and drug efﬂux pathways [57,58]. It has also been shown
that prolonged activation of Nrf2 in murine epidermis may cause
corneocyte fragility and impaired desquamation [59]. It therefore
seems prudent to distinguish between photoprotective strategies
that aim at acute versus chronic Nrf2 modulation, and it remains to
be seen if Nrf2 activators can be used as safe combinatorial agents
together with established sunscreen formulations.
Taken together, our data demonstrate for the ﬁrst time the
feasibility of using tanshinone-based Nrf2-activators as novel skin
photoprotectants. In the future, molecular mechanism of action
and performance of these agents must be tested more rigorously
as a function of solar spectral range in acute and chronic models of
human skin photodamage. Moreover, their efﬁcacy as single or
combinatorial photoprotective ingredients optimized for targe-
ted topical delivery, photostability, and long-term safety should be
evaluated.
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